Clinical Trial NCT06799546

Trial

Haisco HSK39297-301 (NCT06799546)

Clinical trial ID

NCT06799546

Drug name

HSK39297 tablets

Company:

Haisco Pharmaceutical Group Co.

Drug trade name

Eculizumab Injection

Clinicaltrials.gov

Learn more

Phase of study

3

Current status

Recruiting

Start

02/2025

Substance

Research question

To evaluate the efficacy and safety of HSK39297 tablets compared to eculizumab in Patients with PNH who Are Naive to Complement Inhibitor Therapy.

Delivery method of drug

Frequency

Clinical trial locations

China